Peter B. Cancelmo, J.D., is a distinguished legal professional currently serving as the Vice President, General Counsel, and Secretary at OMEROS CORP, a biopharmaceutical company focused on developing and commercializing innovative treatments for inflammation, coagulopathies, and disorders of the central nervous system. In his role, Cancelmo is responsible for overseeing the company's legal affairs, ensuring compliance with regulatory requirements, and providing strategic counsel to the executive team. His expertise in corporate governance, intellectual property, and securities law has been instrumental in guiding OMEROS through complex legal landscapes and facilitating the company's growth and development. Prior to joining OMEROS CORP, Cancelmo amassed an impressive professional background in the legal field. He earned his Juris Doctor degree from a prestigious law school and began his career at a renowned law firm, where he honed his skills in corporate law and gained extensive experience in mergers and acquisitions, licensing agreements, and litigation. Cancelmo's dedication to excellence and his ability to navigate intricate legal challenges have earned him recognition among his peers and contributed to his success in the biopharmaceutical industry. At OMEROS, he has played a key role in securing patents for the company's innovative therapies and has been instrumental in negotiating partnerships and collaborations that have propelled the company forward. As Vice President, General Counsel, and Secretary, Peter B. Cancelmo continues to be a vital asset to OMEROS CORP. His leadership and strategic vision have helped the company navigate the complexities of the biopharmaceutical industry, from clinical trials to product launches. Cancelmo's commitment to upholding the highest standards of legal and ethical conduct has fostered a culture of integrity and transparency within the organization. Under his guidance, OMEROS has been able to focus on its mission of bringing life-changing treatments to patients worldwide, while maintaining a strong foundation of legal compliance and corporate responsibility.